Friday, 12 October 2018

Nanoparticles show promise in treatment for triple-negative breast cancer


Researchers have found that nanoparticle-encapsulated doxorubicin is promising in the treatment of triple-negative breast cancer. Doxorubicin is a well-known anthracycline drug class used primarily in combination chemotherapy

https://goo.gl/gN8E4p



No comments:

Post a Comment

#Nanomedicine 2019 provides a #platform to discuss recent #innovations and #trends in the #field of #nanomedicine 4th #International #Con...